SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024977
Filing Date
2022-11-14
Accepted
2022-11-14 16:05:07
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbrx-20220930.htm   iXBRL 10-Q 2061390
2 EX-10.1 fbrx-ex10_1.htm EX-10.1 130245
3 EX-31.1 fbrx-ex31_1.htm EX-31.1 21057
4 EX-31.2 fbrx-ex31_2.htm EX-31.2 20778
5 EX-32.1 fbrx-ex32_1.htm EX-32.1 11903
6 EX-32.2 fbrx-ex32_2.htm EX-32.2 11951
  Complete submission text file 0000950170-22-024977.txt   6115729

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fbrx-20220930_pre.xml EX-101.PRE 218925
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fbrx-20220930_lab.xml EX-101.LAB 316472
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fbrx-20220930_cal.xml EX-101.CAL 22058
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fbrx-20220930.xsd EX-101.SCH 33999
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fbrx-20220930_def.xml EX-101.DEF 112209
45 EXTRACTED XBRL INSTANCE DOCUMENT fbrx-20220930_htm.xml XML 925661
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 221385053
SIC: 2834 Pharmaceutical Preparations